These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38689745)

  • 1. Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management.
    Leowattana W; Leowattana P; Leowattana T
    World J Hepatol; 2024 Apr; 16(4):550-565. PubMed ID: 38689745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas.
    Lazarevic I; Banko A; Miljanovic D; Cupic M
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients.
    Li MR; Zheng HW; Ma SM; Liu YY; Qie LX; Li JQ; Wang DH; Sun XL; Ren GF; Zheng YH; Wang YL; Dai EH
    J Chin Med Assoc; 2018 Dec; 81(12):1052-1059. PubMed ID: 30143430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.
    Li MR; Zheng HW; Lu JH; Ma SM; Ye LH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH; Sun DX
    Oncotarget; 2017 Feb; 8(7):11063-11070. PubMed ID: 28052021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients.
    Wang WX; Jia R; Gao YY; Liu JY; Luan JQ; Qiao F; Liu LM; Zhang XN; Wang FS; Fu J
    Front Immunol; 2022; 13():894410. PubMed ID: 35958609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection.
    Song LW; Liu PG; Liu CJ; Zhang TY; Cheng XD; Wu HL; Yang HC; Hao XK; Yuan Q; Zhang J; Kao JH; Chen DS; Chen PJ; Xia NS
    Clin Microbiol Infect; 2015 Feb; 21(2):197-203. PubMed ID: 25658546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum qAnti-HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg-positive immune active patients.
    Wang X; Gao X; Wu R; Chi X; Xu H; Guan Y; Jin Q; Niu J
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1806-1814. PubMed ID: 35509262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Hepatitis B Core-Related Antigen and Anti-Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus-Hepatitis B Coinfection.
    Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Lacombe K; Boyd A
    J Infect Dis; 2020 May; 221(11):1826-1837. PubMed ID: 31960918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.
    Hou FQ; Song LW; Yuan Q; Fang LL; Ge SX; Zhang J; Sheng JF; Xie DY; Shang J; Wu SH; Sun YT; Wei SF; Wang MR; Wan MB; Jia JD; Luo GH; Tang H; Li SC; Niu JQ; Zhou WD; Sun L; Xia NS; Wang GQ
    Theranostics; 2015; 5(3):218-26. PubMed ID: 25553110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections.
    Shi Y; Wang Z; Ge S; Xia N; Yuan Q
    Viruses; 2023 May; 15(5):. PubMed ID: 37243197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of anti-HBc quantification in hepatitis B virus related acute-on-chronic liver failure.
    Li J; Gong QM; Xie PL; Lin JY; Chen J; Wei D; Yu DM; Han Y; Zhang XX
    J Gastroenterol Hepatol; 2021 May; 36(5):1291-1299. PubMed ID: 33091955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
    Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
    Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady Decline of HBV DNA Load under NAs in Lymphoma Patients and a Higher Level of qAnti-HBc Predict HBV Reactivation.
    Liu Y; Nuersulitan R; Zhang C; Huo N; Li J; Song Y; Zhu J; Liu W; Zhao H
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202030
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir.
    Cruchet R; Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Lacombe K; Boyd A
    Open Forum Infect Dis; 2020 Jul; 7(7):ofaa215. PubMed ID: 33123612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationship between qAnti-HBc and liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase based on liver biopsy.
    Zhang C; Liu Y; Li J; Liu H; Shao C; Liu D; Yu M; Xi H; Zhao H; Wang G
    J Med Virol; 2022 Aug; 94(8):3911-3923. PubMed ID: 35419853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.
    Li J; Zhang TY; Song LW; Qi X; Yu XP; Li FH; Zhou P; Qin YL; Yang L; Zhao JH; Mao RC; Zhang YM; Wang JY; Yang FF; Zhu HX; Yang SS; Huang YX; Yuan Q; Zhang J; Zhang JM; Xia NS
    Hepatol Res; 2018 Feb; 48(3):E133-E145. PubMed ID: 28707778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of qAnti-HBc with antiviral efficacy in children with chronic hepatitis B and exploration of its possible immune mechanism].
    Zhou YZ; Chang YN; He Y; Wang HM; Peng XR; Chen M; Peng ML; Hu P; Ren H; Xu HM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):837-843. PubMed ID: 34638201
    [No Abstract]   [Full Text] [Related]  

  • 19. Robust
    Zhang YL; Gao Y; Cao JL; Zhao JH; Zhang TY; Yang CL; Xiong HL; Wang YB; Ou SH; Cheng T; Chen CR; Yuan Q; Xia NS
    Emerg Microbes Infect; 2019; 8(1):724-733. PubMed ID: 31130075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
    PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.